JW Therapeutics' Corporate Minority - II Round

JW Therapeutics raised a round of funding on April 08, 2016. Investors include WuXi AppTec.

JW Therapeutics (药明巨诺) is an independent immuno-cell therapy company focused on the cancer market. The company is committed to the development, transformation, and promotion of first in class …

Articles about JW Therapeutics' Corporate Minority - II Round: